HomeBLTE • NASDAQ
Belite Bio Inc
Follow
$69.48
1.27%
Pre-market:(1.76%)+1.22
$70.70
Closed: Mar 13, 4:05:32 AM GMT-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 9.74M | -11.14% |
Net income | -8.68M | 20.63% |
Net profit margin | — | — |
Earnings per share | -0.28 | 30.00% |
EBITDA | -9.71M | 11.33% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | 115.82M | 101.09% |
Total liabilities | 3.62M | -24.63% |
Total equity | 112.20M | — |
Shares outstanding | 30.88M | — |
Price to book | 18.90 | — |
Return on assets | -20.79% | — |
Return on capital | -21.47% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -8.68M | 20.63% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
Previous close
$68.61
Day range
$68.95 - $70.19
Year range
$31.01 - $86.20
Market cap
2.21B USD
Avg Volume
45.16K
Primary exchange
NASDAQ
About
Founded
2016
Website
Employees
20
